These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7557434)

  • 1. A splice donor site mutation results in the insertion of five extra amino acids into P53 from SEWA mouse sarcoma cells.
    Magnusson KP; Minarovits J; Klein G; Wiman KG
    Gene; 1995 Sep; 162(2):231-4. PubMed ID: 7557434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts.
    Magnusson KP; Sandström M; Ståhlberg M; Larsson M; Flygare J; Hellgren D; Wiman KG; Ljungquist S
    Gene; 2000 Apr; 246(1-2):247-54. PubMed ID: 10767546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.
    Laverdière M; Beaudoin J; Lavigueur A
    Nucleic Acids Res; 2000 Mar; 28(6):1489-97. PubMed ID: 10684946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
    Takahashi T; D'Amico D; Chiba I; Buchhagen DL; Minna JD
    J Clin Invest; 1990 Jul; 86(1):363-9. PubMed ID: 2164047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent p53 mutations in chemically induced murine fibrosarcoma.
    Halevy O; Rodel J; Peled A; Oren M
    Oncogene; 1991 Sep; 6(9):1593-600. PubMed ID: 1923526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splice-acceptor site mutation in p53 gene of hu888 zebrafish line.
    Piasecka A; Brzuzan P; Woźny M; Ciesielski S; Kaczmarczyk D
    J Appl Genet; 2015 Feb; 56(1):115-21. PubMed ID: 25183022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma.
    Sameshima Y; Akiyama T; Mori N; Mizoguchi H; Toyoshima K; Sugimura T; Terada M; Yokota J
    Biochem Biophys Res Commun; 1990 Dec; 173(2):697-703. PubMed ID: 2175605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of SEWA sarcoma cell proteins with the intracisternal A-type particle long terminal repeat DNA sequence.
    Ronai Z; Robinson R; Lee G; Okin E; Minarovits J; Wirchubsky Z; Klein G; Weinstein IB
    Mol Carcinog; 1992; 5(1):81-9. PubMed ID: 1543543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.
    Will K; Warnecke G; Bergmann S; Deppert W
    Nucleic Acids Res; 1995 Oct; 23(20):4023-8. PubMed ID: 7479059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cell responses to self- and mutated p53 determinants during tumorigenesis in mice.
    Fedoseyeva EV; Boisgérault F; Anosova NG; Wollish WS; Arlotta P; Jensen PE; Ono SJ; Benichou G
    J Immunol; 2000 Jun; 164(11):5641-51. PubMed ID: 10820239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?
    Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG
    Oncogene; 1998 Nov; 17(18):2333-7. PubMed ID: 9811464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human tumour suppressor gene p53 is alternatively spliced in normal cells.
    Flaman JM; Waridel F; Estreicher A; Vannier A; Limacher JM; Gilbert D; Iggo R; Frebourg T
    Oncogene; 1996 Feb; 12(4):813-8. PubMed ID: 8632903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the p53 gene expression by a splice donor site mutation in a human T-cell leukemia cell line.
    Soudon J; Caron de Fromentel C; Bernard O; Larsen CJ
    Leukemia; 1991 Oct; 5(10):917-20. PubMed ID: 1961027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas.
    Shimokado K; Watanabe H; Sumii M; Miyagawa K; Kamiya K; Dohi K; Niwa O
    Jpn J Cancer Res; 1998 Mar; 89(3):269-77. PubMed ID: 9600120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of tumor suppressor gene p53 in chicken lymphoblastoid tumor cell lines and field tumors.
    Takagi M; Ohashi K; Morimura T; Sugimoto C; Onuma M
    J Vet Med Sci; 1998 Aug; 60(8):923-9. PubMed ID: 9764405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in c-myc and pvt-1 amplification in SEWA sarcoma sublines selected for adherent or non-adherent growth.
    Minarovits J; Steinitz M; Boldog F; Imreh S; Wirschubsky Z; Ingvarsson S; Hedenskog M; Minarovits-Kormuta S; Klein G
    Int J Cancer; 1990 Mar; 45(3):514-20. PubMed ID: 2307540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.
    Hsu HC; Huang AM; Lai PL; Chien WM; Peng SY; Lin SW
    Hepatology; 1994 Jan; 19(1):122-8. PubMed ID: 7903951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons.
    Balcer-Kubiczek EK; Yin J; Lin K; Harrison GH; Abraham JM; Meltzer SJ
    Radiat Res; 1995 Jun; 142(3):256-62. PubMed ID: 7761574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of myelodysplastic syndrome with an intronic point mutation of the p53 tumour suppressor gene at the splice donor site.
    Kikukawa M; Aoki N; Mori M
    Br J Haematol; 1998 Mar; 100(3):564-6. PubMed ID: 9504641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.